跳至主要内容
临床试验/NCT02714621
NCT02714621已完成不适用

Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU): A Feasibility Study for Treating Recurrent Gynaecological Malignancies

Institute of Cancer Research, United Kingdom2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31
试验地点
2
主要终点
Changes in pain, measured using a patient diary

研究概览

简要总结

The primary objective of this pilot study is to determine whether or not it is feasible to use MRgHIFU to treat symptomatic (pain, bleeding) recurrent pelvic malignancy with an acceptable safety profile when conventional treatment options are not available. The ultimate goal is to be able not only to offer a viable method of symptom palliation in patients with recurrent pelvic tumours and improve their quality of life; but also to control tumour growth and extend life in a group of relatively young patients with isolated local recurrence.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with recurrent pelvic gynaecological malignancy (cervix and endometrial cancer).
  • Recurrent lesion is painful (NRS>4) and not suitable for alternative treatments
  • Intended target volume accessible for MRgHIFU treatment
  • Intended target volume visible on noncontrast MR imaging
  • Distance between target and skin ≥1cm

排除标准

  • MRI contraindicated (e.g. by incompatible metal implants or claustrophobia)
  • Pregnancy
  • Sedation contraindicated
  • MRI contrast agent contraindicated
  • Scar, internal or external fixation device along the beam path or at the target

结局指标

主要结局

Changes in pain, measured using a patient diary

时间窗: 7 days post-treatment, follow up at 90 days

次要结局

  • Changes in bleeding, measured using a questionnaire(7 days post-treatment, follow up at 90 days)

研究者

发起方
Institute of Cancer Research, United Kingdom
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nandita deSouza

Professor of Translational Imaging

Institute of Cancer Research, United Kingdom

研究点 (2)

Loading locations...

相似试验

MR-HIFU for Recurrent Gynaecological Cancer | 临床试验